NAMI Corp. (NASDAQ:NAMI – Get Free Report) saw a significant decrease in short interest in the month of October. As of October 15th, there was short interest totaling 94,100 shares, a decrease of 69.0% from the September 30th total of 303,550 shares. Approximately 3.0% of the company’s stock are sold short. Based on an average daily volume of 32,933 shares, the short-interest ratio is currently 2.9 days.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings lowered shares of NAMI from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, September 29th. One investment analyst has rated the stock with a Sell rating. According to MarketBeat, NAMI presently has an average rating of “Sell”.
Check Out Our Latest Stock Analysis on NAMI
NAMI Stock Performance
NAMI stock traded up $0.07 during mid-day trading on Thursday, reaching $1.91. The stock had a trading volume of 9,489 shares, compared to its average volume of 777,318. NAMI has a one year low of $1.51 and a one year high of $26.75. The company has a 50-day moving average price of $2.13 and a two-hundred day moving average price of $8.00.
NAMI (NASDAQ:NAMI – Get Free Report) last announced its quarterly earnings data on Tuesday, September 22nd. The company reported ($3.31) earnings per share for the quarter. The company had revenue of $10.46 million for the quarter.
NAMI Company Profile
Jinxin Technology Holding Co engages in the provision of digital content services. The company was founded in August 2015 and is headquartered in Shanghai, China.
Recommended Stories
- Five stocks we like better than NAMI
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for NAMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NAMI and related companies with MarketBeat.com's FREE daily email newsletter.
